Abilify and Zemuron drug interactions - a phase IV clinical study of FDA data

Summary:

The phase IV clinical study analyzes what interactions people have when they take Abilify and Zemuron. It is created by eHealthMe based on reports of 5 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,451 Abilify users. Check the latest studies of Abilify.

What is Zemuron?

Zemuron has active ingredients of rocuronium bromide. eHealthMe is studying from 873 Zemuron users. Check the latest studies of Zemuron.

On May, 08, 2026

5 people who take Abilify and Zemuron together, and have interactions are studied.

What are the common drug interactions of Abilify and Zemuron, by gender? *:

female:

Chronic kidney disease
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)
Pancreatitis acute (sudden inflammation of pancreas)
Parathyroid tumour benign (parathyroid tumour non-cancerous)

male:

Agitation (state of anxiety or nervous excitement)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
Parkinsonian rest tremor
Psychotic disorder
Somnolence (a state of near-sleep, a strong desire for sleep)
Anxiety
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

What are the common drug interactions of Abilify and Zemuron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pancreatitis acute (sudden inflammation of pancreas)

40-49:

Chronic kidney disease
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Renal failure (kidney dysfunction)
Renal tubular necrosis (death of kidney tubules)

50-59:

Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)
Parathyroid tumour benign (parathyroid tumour non-cancerous)

60+:

Agitation (state of anxiety or nervous excitement)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
Parkinsonian rest tremor
Psychotic disorder
Somnolence (a state of near-sleep, a strong desire for sleep)
Anxiety
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Zemuron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously